🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Celcuity Inc.

Celcuity Inc. logo
Market Cap: Medium
Employees: Lowest

CELsignia diagnostic platform

Celcuity Inc., a biotechnology company, develops targeted therapies for cancer patients in the US, including the CELsignia diagnostic platform and Gedatolisib drug candidate.

Tags: Gedatolisib, HER2-negative, biotechnology, breast cancer, cancer therapy, diagnostic platform

Website

About | Leadership | Directors | About | Contact | News | News | News | About | About

Symbol: CELC

Recent Price: $13.13

Industry: Biotechnology

CEO: Mr. Brian F. Sullivan

Sector: Healthcare

Employees: 55

Address: 16305–36th Avenue North, Minneapolis, MN 55446

Phone: 763 392 0767

Leadership

  • Brian Sullivan, CEO and Co-founder
  • Lance Laing, PhD, Chief Science Officer and Co-founder
  • Vicky Hahne, CFO
  • Igor Gorbatchevsky, MD, Chief Medical Officer
  • Eldon Mayer, Chief Commercial Officer
  • Brent Eilefson, General Counsel
  • Bernhard Lampert, PhD, VP of Pharmaceutical Development
  • Nadene Zack, VP Clinical Operations
  • Sunni Miller, VP of Regulatory Affairs
  • David Bridge, VP of Quality Assurance and Process Development
  • William Strickland, PharmD, VP of Medical Affairs
  • Fred Kerwood, VP of Program Management
  • Charlotte Moser, MD, PhD, SVP of Clinical Development
  • John R. MacDonald, PhD, SVP of R&D
  • Lance Laing, PhD, Chief Science Officer and Co-Founder
  • Richard Buller, MD, PhD, Director
  • David F. Dalvey, Director
  • Leo Furcht, MD, Director
  • Polly Murphy, DVM, PhD, Director
  • Richard J. Nigon, Director

Last updated: 2024-12-31